NCT00840476View on ClinicalTrials.gov

Meloxicam 15 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Meloxicam 15 mg Tablets

1 x 15 mg, single-dose fasting

DRUG

Mobic® 15 mg Tablets

1 x 15 mg, single-dose fasting

Trial Locations (1)

M1L4S4

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840476 - Meloxicam 15 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter